Literature DB >> 23428797

Integrin signaling in control of tumor growth and progression.

Jiangling Xiong1, Hayri E Balcioglu, Erik H J Danen.   

Abstract

Interactions with the extracellular matrix (ECM) provide cells with physical and chemical cues that act in concert with growth factors to support survival and proliferation. Transmembrane receptors of the integrin family mediate ECM attachment and play important roles in sensing and responding to ECM properties. Integrin signaling involves large integrin-associated intracellular protein complexes that act as anchors for the cytoskeleton and as signaling hotspots where enzymes and substrates are concentrated. Moreover, many different growth factor signaling cascades are amplified when cells are attached to the ECM. Integrins are involved in many pathologies; here we focus on their roles in cancer. Although "anchorage-independence" is a hallmark of cancer cells, genetic studies clearly show that integrins and associated proteins provide essential support for early tumor development and growth. Integrins also provide support during later stages of tumor progression but in some scenarios they appear to have suppressive activity, which is currently not understood.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428797     DOI: 10.1016/j.biocel.2013.02.005

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  25 in total

Review 1.  Lipid Metabolism in Tumor-Associated Fibroblasts.

Authors:  Hongzhong Li; Jingyuan Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Upregulation of CPNE3 suppresses invasion, migration and proliferation of glioblastoma cells through FAK pathway inactivation.

Authors:  Dijian Shi; Bo Lin; Jun Lai; Kaipeng Li; Yimo Feng
Journal:  J Mol Histol       Date:  2021-03-16       Impact factor: 2.611

3.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

4.  Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain.

Authors:  Jianbo Yang; Matthew A Price; Leah E C Wanshura; Jinsong He; Mei Yi; Danny R Welch; Guiyuan Li; Sean Conner; Jonathan Sachs; Eva A Turley; James B McCarthy
Journal:  Melanoma Res       Date:  2019-08       Impact factor: 3.599

Review 5.  The extracellular matrix modulates the hallmarks of cancer.

Authors:  Michael W Pickup; Janna K Mouw; Valerie M Weaver
Journal:  EMBO Rep       Date:  2014-11-08       Impact factor: 8.807

Review 6.  Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment.

Authors:  Wiam El Kheir; Bernard Marcos; Nick Virgilio; Benoit Paquette; Nathalie Faucheux; Marc-Antoine Lauzon
Journal:  Pharmaceutics       Date:  2022-06-01       Impact factor: 6.525

Review 7.  Physiological, Tumor, and Metastatic Niches: Opportunities and Challenges for Targeting the Tumor Microenvironment.

Authors:  Meera Murgai; Amber Giles; Rosandra Kaplan
Journal:  Crit Rev Oncog       Date:  2015

Review 8.  Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy.

Authors:  Annele Sainio; Hannu Järveläinen
Journal:  Mol Cell Ther       Date:  2014-05-02

9.  Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix.

Authors:  Leila Akkari; Vasilena Gocheva; Jemila C Kester; Karen E Hunter; Marsha L Quick; Lisa Sevenich; Hao-Wei Wang; Christoph Peters; Laura H Tang; David S Klimstra; Thomas Reinheckel; Johanna A Joyce
Journal:  Genes Dev       Date:  2014-10-01       Impact factor: 11.361

Review 10.  Lipid metabolism, apoptosis and cancer therapy.

Authors:  Chunfa Huang; Carl Freter
Journal:  Int J Mol Sci       Date:  2015-01-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.